Chinese Biotech Co. Pulls Back Suit Over Biased H-1B Denials
A Chinese biotech firm has dropped its suit accusing the U.S. Department of Homeland Security of abusing its discretion by denying H-1B visa petitions for two prospective financial analysts, according to...To view the full article, register now.
Already a subscriber? Click here to view full article